Healthcare provider profile · identity verified

Magalys Torres, M.D.

Family Practice · WELLINGTON, FL · NPI 1750716676

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	184
Amlodipine Besylate	Amlodipine Besylate	445	163
Levothyroxine Sodium	Levothyroxine Sodium	307	112
Losartan Potassium	Losartan Potassium	305	129
Rosuvastatin Calcium	Rosuvastatin Calcium	260	120
Metformin Hcl	Metformin Hcl	247	99
Lisinopril	Lisinopril	246	100
Pantoprazole Sodium	Pantoprazole Sodium	184	89
Hydrochlorothiazide	Hydrochlorothiazide	152	60
Tamsulosin Hcl	Tamsulosin Hcl	148	50
Alprazolam	Alprazolam	141	42
Fluticasone Propionate	Fluticasone Propionate	136	92
Albuterol Sulfate Hfa	Albuterol Sulfate	127	48
Temazepam	Temazepam	108	28
Omeprazole	Omeprazole	95	38
Gabapentin	Gabapentin	94	47
Meloxicam	Meloxicam	94	51
Alendronate Sodium	Alendronate Sodium	89	42
Metoprolol Succinate	Metoprolol Succinate	89	41
Escitalopram Oxalate	Escitalopram Oxalate	83	31
Jardiance	Empagliflozin	77	29
Famotidine	Famotidine	76	27
Carvedilol	Carvedilol	74	29
Doxycycline Hyclate	Doxycycline Hyclate	74	65
Metoprolol Tartrate	Metoprolol Tartrate	73	30
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	63	53
Methylprednisolone	Methylprednisolone	62	54
Montelukast Sodium	Montelukast Sodium	61	24
Ozempic	Semaglutide	61	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	49
Furosemide	Furosemide	57	32
Azithromycin	Azithromycin	53	45
Simvastatin	Simvastatin	53	23
Trazodone Hcl	Trazodone Hcl	52	21
Eliquis	Apixaban	50	16
Glimepiride	Glimepiride	49	22
Glipizide	Glipizide	49	29
Ciclopirox	Ciclopirox	44	19
Sertraline Hcl	Sertraline Hcl	43	15
Tramadol Hcl	Tramadol Hcl	42	20
Zolpidem Tartrate	Zolpidem Tartrate	42	suppressed
Clonazepam	Clonazepam	40	18
Mupirocin	Mupirocin	40	29
Clopidogrel	Clopidogrel Bisulfate	39	20
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	19
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	11
Metformin Hcl Er	Metformin Hcl	38	20
Allopurinol	Allopurinol	37	13
Januvia	Sitagliptin Phosphate	37	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	12
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	37	29
Hydralazine Hcl	Hydralazine Hcl	36	17
Benazepril Hcl	Benazepril Hcl	35	suppressed
Finasteride	Finasteride	34	suppressed
Spiriva Handihaler	Tiotropium Bromide	32	suppressed
Prednisone	Prednisone	31	23
Symbicort	Budesonide/Formoterol Fumarate	31	suppressed
Baclofen	Baclofen	30	suppressed
Lorazepam	Lorazepam	30	11
Glipizide Er	Glipizide	29	11
Mounjaro	Tirzepatide	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	20
Vitamin D2	Ergocalciferol (Vitamin D2)	29	17
Lovastatin	Lovastatin	27	suppressed
Atenolol	Atenolol	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Ezetimibe	Ezetimibe	25	13
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	16
Memantine Hcl	Memantine Hcl	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	13
Cefuroxime	Cefuroxime Axetil	23	20
Linzess	Linaclotide	23	12
Pravastatin Sodium	Pravastatin Sodium	23	11
Amoxicillin	Amoxicillin	22	19
Celecoxib	Celecoxib	22	13
Donepezil Hcl	Donepezil Hcl	22	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	17
Ibuprofen	Ibuprofen	21	15
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Ketoconazole	Ketoconazole	20	11
Torsemide	Torsemide	19	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	14
Fluconazole	Fluconazole	18	13
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	18	suppressed
Potassium Chloride	Potassium Chloride	18	suppressed
Sildenafil Citrate	Sildenafil Citrate	18	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Nifedipine Er	Nifedipine	14	13
Bumetanide	Bumetanide	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Valsartan	Valsartan	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Labetalol Hcl	Labetalol Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error